MA41941A - Procédé de purification de protéines - Google Patents

Procédé de purification de protéines

Info

Publication number: MA41941A
Authority: MA; Morocco
Prior art keywords: purification process; protein purification; protein; purification
Prior art date: 2015-04-22

Application number

MA041941A

Other languages

English (en)

Inventor

Sam Philip Heywood

Gavin Barry Wild

Original Assignee

Ucb Biopharma Sprl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-04-22

Filing date

2016-04-20

Publication date

2018-02-28

2016-04-20 Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl

2018-02-28 Publication of MA41941A publication Critical patent/MA41941A/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/624—Disulfide-stabilized antibody (dsFv)

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Life Sciences & Earth Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

MA041941A 2015-04-22 2016-04-20 Procédé de purification de protéines MA41941A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB1506868.7A GB201506868D0 (en)	2015-04-22	2015-04-22	Method for protein purification

Publications (1)

Publication Number	Publication Date
MA41941A true MA41941A (fr)	2018-02-28

Family

ID=53299017

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA041941A MA41941A (fr)	2015-04-22	2016-04-20	Procédé de purification de protéines

Country Status (19)

Country	Link
US (2)	US10927164B2 (fr)
EP (1)	EP3286205A1 (fr)
JP (2)	JP6866300B2 (fr)
KR (1)	KR102675400B1 (fr)
CN (1)	CN107636012B (fr)
AR (1)	AR104358A1 (fr)
AU (1)	AU2016251223B2 (fr)
BR (1)	BR112017022073A2 (fr)
CA (1)	CA2983057A1 (fr)
CL (1)	CL2017002614A1 (fr)
CO (1)	CO2017010631A2 (fr)
EA (1)	EA201792328A1 (fr)
GB (1)	GB201506868D0 (fr)
IL (1)	IL254883B (fr)
MA (1)	MA41941A (fr)
MX (1)	MX2017013333A (fr)
MY (1)	MY189854A (fr)
SG (1)	SG11201708256YA (fr)
WO (1)	WO2016169992A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9657055B2 (en) *	2011-11-30	2017-05-23	Ge Healthcare Bioprocess R&D Ab	Affinity chromatography matrix
GB201506869D0 (en)	2015-04-22	2015-06-03	Ucb Biopharma Sprl	Method
GB201506870D0 (en)	2015-04-22	2015-06-03	Ucb Biopharma Sprl	Method
CN108085358A (zh) *	2018-02-08	2018-05-29	保定冀中药业有限公司	一种犬细小病毒单克隆抗体IgG2b-Fab片段的制备方法
EP4007771A1 (fr)	2019-08-02	2022-06-08	UCB Biopharma SRL	Procédés de purification d'anticorps
GB201919058D0 (en) *	2019-12-20	2020-02-05	Ucb Biopharma Sprl	Multi-specific antibodies
BR112022011993A2 (pt) *	2019-12-26	2022-09-20	Abl Bio Inc	Método para purificar peptídeo biologicamente ativo usando cromatografia de afinidade de proteína a
GB202109246D0 (en) *	2021-06-28	2021-08-11	Cytiva Bioprocess R & D Ab	A method of separating bispecific antibodies

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5429746A (en)	1994-02-22	1995-07-04	Smith Kline Beecham Corporation	Antibody purification
AU777005B2 (en) *	1999-05-15	2004-09-30	University Of California, San Diego	Protein A based binding domains with desirable activities
CZ20031983A3 (cs) *	2000-12-29	2005-07-13	Savient Pharmaceuticals, Inc.	Specifické protilátky pro selektivní léčbu rakoviny
JPWO2004087761A1 (ja) *	2003-03-31	2006-07-27	麒麟麦酒株式会社	ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
US20110144311A1 (en) *	2008-08-14	2011-06-16	Rebecca Chmielowski	Methods for purifying antibodies using protein a affinity chromatography
JP5782385B2 (ja)	2009-02-17	2015-09-24	ユーシービーファーマソシエテアノニム	ヒトｏｘ４０に対する特異性を有する抗体分子
CN103189390A (zh) *	2010-11-01	2013-07-03	帝斯曼知识产权资产管理有限公司	单一单元离子交换色谱抗体纯化
WO2012074463A1 (fr)	2010-11-29	2012-06-07	Ge Healthcare Bio-Sciences Ab	Matrice de chromatographie d'affinité
SG11201401649VA (en)	2011-11-11	2014-07-30	Ucb Pharma Sa	Albumin binding antibodies and binding fragments thereof
UA112203C2 (uk)	2011-11-11	2016-08-10	Юсб Фарма С.А.	Злитий білок біоспецифічного антитіла, який зв'язується з ox40 людини та сироватковим альбуміном людини
WO2013119966A2 (fr) *	2012-02-10	2013-08-15	Genentech, Inc.	Anticorps et autres hétéromultimères monocaténaires
GB201223276D0 (en)	2012-12-21	2013-02-06	Ucb Pharma Sa	Antibodies and methods of producing same
US9493563B2 (en) *	2013-11-04	2016-11-15	Glenmark Pharmaceuticals S.A.	Production of T cell retargeting hetero-dimeric immunoglobulins
GB201506870D0 (en)	2015-04-22	2015-06-03	Ucb Biopharma Sprl	Method
GB201506869D0 (en)	2015-04-22	2015-06-03	Ucb Biopharma Sprl	Method

2015
- 2015-04-22 GB GBGB1506868.7A patent/GB201506868D0/en not_active Ceased
2016
- 2016-04-20 SG SG11201708256YA patent/SG11201708256YA/en unknown
- 2016-04-20 MY MYPI2017703933A patent/MY189854A/en unknown
- 2016-04-20 AU AU2016251223A patent/AU2016251223B2/en active Active
- 2016-04-20 JP JP2017555232A patent/JP6866300B2/ja active Active
- 2016-04-20 US US15/566,231 patent/US10927164B2/en active Active
- 2016-04-20 EP EP16717915.9A patent/EP3286205A1/fr active Pending
- 2016-04-20 MA MA041941A patent/MA41941A/fr unknown
- 2016-04-20 BR BR112017022073A patent/BR112017022073A2/pt active Search and Examination
- 2016-04-20 KR KR1020177033687A patent/KR102675400B1/ko active IP Right Grant
- 2016-04-20 WO PCT/EP2016/058774 patent/WO2016169992A1/fr active Application Filing
- 2016-04-20 CN CN201680028589.3A patent/CN107636012B/zh active Active
- 2016-04-20 MX MX2017013333A patent/MX2017013333A/es unknown
- 2016-04-20 CA CA2983057A patent/CA2983057A1/fr active Pending
- 2016-04-20 EA EA201792328A patent/EA201792328A1/ru unknown
- 2016-04-22 AR ARP160101122A patent/AR104358A1/es unknown
2017
- 2017-10-03 IL IL254883A patent/IL254883B/en unknown
- 2017-10-16 CL CL2017002614A patent/CL2017002614A1/es unknown
- 2017-10-18 CO CONC2017/0010631A patent/CO2017010631A2/es unknown
2021
- 2021-01-07 JP JP2021001584A patent/JP2021066734A/ja not_active Abandoned
- 2021-02-17 US US17/177,236 patent/US20210171609A1/en active Pending

Also Published As

Publication number	Publication date
US10927164B2 (en)	2021-02-23
SG11201708256YA (en)	2017-11-29
IL254883B (en)	2021-09-30
EP3286205A1 (fr)	2018-02-28
GB201506868D0 (en)	2015-06-03
AU2016251223A1 (en)	2017-10-26
US20210171609A1 (en)	2021-06-10
CN107636012A (zh)	2018-01-26
KR102675400B1 (ko)	2024-06-13
BR112017022073A2 (pt)	2018-08-14
JP2021066734A (ja)	2021-04-30
KR20170139131A (ko)	2017-12-18
CL2017002614A1 (es)	2018-04-27
AU2016251223B2 (en)	2021-12-09
MX2017013333A (es)	2018-02-19
AR104358A1 (es)	2017-07-12
CO2017010631A2 (es)	2018-01-05
WO2016169992A1 (fr)	2016-10-27
US20180100007A1 (en)	2018-04-12
CN107636012B (zh)	2022-08-02
JP6866300B2 (ja)	2021-04-28
EA201792328A1 (ru)	2018-05-31
JP2018520089A (ja)	2018-07-26
IL254883A0 (en)	2017-12-31
CA2983057A1 (fr)	2016-10-27
MY189854A (en)	2022-03-14

Publication	Publication Date	Title
DK3292137T3 (da)	2022-10-17	Proteiner specifikke for cd137
MA41941A (fr)	2018-02-28	Procédé de purification de protéines
DK3341479T3 (da)	2020-02-24	LNA-G-Proces
MA45017A (fr)	2019-03-27	Procédé de récupération de phosphate
FI20155351A (fi)	2016-11-14	Vedenpuhdistus
IL261040B (en)	2021-07-29	Protein purification
FI20155350A (fi)	2016-11-14	Vedenpuhdistus
MA43944A (fr)	2018-12-12	Procédé de purification de liquide
ZA201903408B (en)	2021-02-24	Process for purification of pyrazolpyridazines
SG11201710689TA (en)	2018-01-30	Process of purifying methionine
SG11201607098SA (en)	2016-09-29	Antibody purification process
DK3223869T3 (da)	2021-08-02	Gelatineoprensning
FR3021230B1 (fr)	2016-06-24	Procede de purification de nanofils metalliques
MA46454A (fr)	2019-08-14	Procédé multi-protéase
BR112016027819A2 (pt)	2017-08-22	Processo de preparação de derivados de tiazole
BR112016019246A2 (pt)	2017-10-10	processo paraa fabricação de hidroclorofluoro-olefinas
SG11201802755WA (en)	2018-05-30	Process for purification of methyl methacrylate
HK1257713A1 (zh)	2019-10-25	用於蛋白純化的方法
DK3197589T3 (da)	2019-08-12	Fremgangsmåde til oprensning af væsker
BR112016019843A2 (pt)	2018-06-19	processo de biorrefinamento
MA47014A (fr)	2019-10-23	Procédé de purification d'antibiotiques lipopeptidiques
MA42658A (fr)	2021-03-31	Procédé de réduction de pathogènes
GB201617240D0 (en)	2016-11-23	Purification process
FR3033231B1 (fr)	2018-05-11	Procede de decongelation
GB201520903D0 (en)	2016-01-13	Purification method